SHE:300601 - Shenzhen Kangtai Biological Products Co Ltd

Shenzhen Kangtai Biological Pr
Sector: Health Care, Industry: Pharmaceuticals

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2015 Q3	2015 Q4	2016 Q1	2016 Q2	2016 Q3	2016 Q4	2017 Q1	2017 Q2	2017 Q3	2017 Q4	2018 Q1	2018 Q2	2018 Q3	2018 Q4	2019 Q1	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	775.21M 179.9%	1.33B 70.9%	1.27B -3.8%	871.43M -31.6%	956.42M 9.8%	737.22M -22.9%	592.34M -19.7%	748.38M 26.3%	982.19M 31.2%	733.9M -25.3%	1.01B 38.0%	451.66M -55.4%
Cost of Revenue	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	123.9M 211.2%	201.38M 62.5%	621.32M 208.5%	122.35M -80.3%	121.03M -1.1%	89.48M -26.1%	167.09M 86.7%	105.44M -36.9%	123.95M 17.6%	114.43M -7.7%	193.86M 69.4%	71.96M -62.9%
Gross Profit	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	651.31M 174.6%	1.12B 72.5%	653.52M -41.8%	749.07M 14.6%	835.39M 11.5%	647.74M -22.5%	425.25M -34.3%	642.95M 51.2%	858.24M 33.5%	619.47M -27.8%	819.11M 32.2%	379.7M -53.6%
Total Expenses	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	422.77M 52.9%	515.07M 21.8%	844.07M 63.9%	533.94M -36.7%	731.9M 37.1%	659.14M -9.9%	595.79M -9.6%	485.37M -18.5%	589.9M 21.5%	540.8M -8.3%	716.89M 32.6%	364.98M -49.1%
Operating Expense	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	298.86M 26.3%	313.69M 5.0%	222.75M -29.0%	411.59M 84.8%	610.88M 48.4%	569.66M -6.7%	428.7M -24.7%	379.93M -11.4%	465.95M 22.6%	426.37M -8.5%	523.03M 22.7%	293.02M -44.0%
Operating Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	352.44M 64876.0%	809.98M 129.8%	430.77M -46.8%	337.48M -21.7%	224.52M -33.5%	78.08M -65.2%	-3.45M -	263.02M -	392.29M 49.1%	193.09M -50.8%	296.09M 53.3%	86.68M -70.7%
Net Income (Cont Operations)	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	336.55M -	-	-	-	120.5M -	-	-	-	510.43M -	-	-	-
Net Income	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	311.4M 1138.0%	699.66M 124.7%	227.16M -67.5%	273.59M 20.4%	-153.09M -	82.64M -	-335.85M -	205.46M -	304.97M 48.4%	186.62M -38.8%	164.25M -12.0%	54.07M -67.1%
Basic EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.283 1128.4%	1.024 261.4%	0.332 -67.5%	0.4 20.4%	-0.227 -	0.074 -	-0.3 -	0.18 -	0.276 53.5%	0.167 -39.5%	0.147 -12.3%	0.05 -65.9%
Diluted EPS	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	0.283 1145.3%	1 253.1%	0.332 -66.8%	0.4 20.4%	-0.227 -	0.074 -	-0.3 -	0.18 -	0.276 53.5%	0.167 -39.5%	0.147 -12.3%	0.05 -65.9%